slower titration delays maximal weight loss, but it preserves the behavioral habits and clinic engagement that actually sustain long-term success
Beyond weight loss, semaglutide has demonstrated cardiovascular benefits in the SELECT trial, showing a 20 percent reduction in major cardiovascular events in overweight and obese patients with established cardiovascular disease
All patients who have taken a double dose should contact NHS 111 or their GP surgery for advice, even if they feel well initially, as symptoms may develop or worsen over the subsequent hours
At present, no FDA-approved generic Semaglutide exists in the United States
Targeted laboratory monitoring based on individual risk factors may include comprehensive metabolic panel, complete blood count, iron studies, vitamin B12 (especially if also taking metformin), and vitamin D
Since many clinics have weight cutoffs before they will even treat a patient, some patients might pursue GLP-1s to meet the requirements, Merhi adds